NASDAQ:AFMD
$0.83
(
-5.23%
)
Friday, 26th May 2023
Affimed N.V. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.82 | $1.11 | Friday, 26th May 2023 AFMD stock ended at $0.83. This is 5.23% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 10.71% from a day low at $0.82 to a day high of $0.91. |
| 90 days | $0.550 | $1.11 | |
| 52 weeks | $0.550 | $3.40 |
Historical Affimed N.V. prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $0.84 | $0.91 | $0.82 | $0.83 | 1 310 421 |
| 2023-05-25 | $1.00 | $1.00 | $0.86 | $0.87 | 1 146 211 |
| 2023-05-24 | $0.97 | $1.01 | $0.95 | $0.97 | 955 682 |
| 2023-05-23 | $1.07 | $1.07 | $0.93 | $0.97 | 1 527 444 |
| 2023-05-22 | $1.09 | $1.11 | $1.03 | $1.07 | 1 059 150 |
| 2023-05-19 | $1.00 | $1.10 | $0.97 | $1.08 | 1 246 562 |
| 2023-05-18 | $0.92 | $0.99 | $0.91 | $0.97 | 1 015 625 |
| 2023-05-17 | $0.89 | $0.93 | $0.85 | $0.92 | 525 066 |
| 2023-05-16 | $0.90 | $0.90 | $0.86 | $0.88 | 300 005 |
| 2023-05-15 | $0.89 | $0.92 | $0.85 | $0.89 | 315 484 |
| 2023-05-12 | $0.91 | $0.95 | $0.85 | $0.87 | 386 315 |
| 2023-05-11 | $0.90 | $0.98 | $0.88 | $0.92 | 732 694 |
| 2023-05-10 | $0.87 | $0.91 | $0.85 | $0.91 | 376 255 |
| 2023-05-09 | $0.89 | $0.90 | $0.85 | $0.87 | 303 654 |
| 2023-05-08 | $0.88 | $0.91 | $0.85 | $0.88 | 401 399 |
| 2023-05-05 | $0.87 | $0.93 | $0.86 | $0.88 | 272 981 |
| 2023-05-04 | $0.84 | $0.90 | $0.84 | $0.86 | 301 033 |
| 2023-05-03 | $0.89 | $0.91 | $0.86 | $0.87 | 329 783 |
| 2023-05-02 | $0.89 | $0.90 | $0.83 | $0.88 | 925 761 |
| 2023-05-01 | $0.88 | $0.94 | $0.87 | $0.91 | 291 085 |
| 2023-04-28 | $0.90 | $0.92 | $0.87 | $0.90 | 327 944 |
| 2023-04-27 | $0.93 | $0.95 | $0.83 | $0.90 | 555 947 |
| 2023-04-26 | $0.84 | $0.95 | $0.84 | $0.93 | 659 951 |
| 2023-04-25 | $0.82 | $0.93 | $0.82 | $0.86 | 1 187 899 |
| 2023-04-24 | $0.82 | $0.85 | $0.80 | $0.83 | 363 684 |
| 2023-04-21 | $0.80 | $0.85 | $0.80 | $0.85 | 466 461 |
| 2023-04-20 | $0.83 | $0.84 | $0.80 | $0.81 | 443 638 |
| 2023-04-19 | $0.80 | $0.85 | $0.80 | $0.83 | 658 471 |
| 2023-04-18 | $0.82 | $0.83 | $0.791 | $0.80 | 555 603 |
| 2023-04-17 | $0.794 | $0.84 | $0.763 | $0.82 | 1 003 969 |
| 2023-04-14 | $0.691 | $0.798 | $0.691 | $0.758 | 828 490 |
| 2023-04-13 | $0.680 | $0.757 | $0.670 | $0.720 | 796 418 |
| 2023-04-12 | $0.696 | $0.716 | $0.661 | $0.672 | 511 512 |
| 2023-04-11 | $0.680 | $0.715 | $0.664 | $0.711 | 653 631 |
| 2023-04-10 | $0.770 | $0.780 | $0.661 | $0.668 | 1 417 223 |
| 2023-04-06 | $0.730 | $0.750 | $0.730 | $0.734 | 597 063 |
| 2023-04-05 | $0.730 | $0.752 | $0.730 | $0.732 | 512 408 |
| 2023-04-04 | $0.750 | $0.766 | $0.730 | $0.739 | 562 730 |
| 2023-04-03 | $0.774 | $0.788 | $0.730 | $0.740 | 398 944 |
| 2023-03-31 | $0.750 | $0.777 | $0.730 | $0.746 | 1 086 994 |
| 2023-03-30 | $0.758 | $0.80 | $0.728 | $0.741 | 719 640 |
| 2023-03-29 | $0.700 | $0.798 | $0.700 | $0.758 | 1 087 631 |
| 2023-03-28 | $0.750 | $0.750 | $0.690 | $0.696 | 822 026 |
| 2023-03-27 | $0.680 | $0.700 | $0.660 | $0.689 | 1 034 259 |
| 2023-03-24 | $0.650 | $0.691 | $0.550 | $0.661 | 1 185 852 |
| 2023-03-23 | $0.85 | $0.85 | $0.676 | $0.702 | 1 633 476 |
| 2023-03-22 | $0.760 | $0.780 | $0.743 | $0.750 | 641 582 |
| 2023-03-21 | $0.744 | $0.786 | $0.744 | $0.765 | 592 345 |
| 2023-03-20 | $0.758 | $0.770 | $0.740 | $0.762 | 567 288 |
| 2023-03-17 | $0.775 | $0.82 | $0.740 | $0.760 | 977 713 |
About Affimed N.V.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
